Pathfinder Cell Therapy, Inc.

PFND · OTC
Analyze with AI
12/31/2014
12/31/2013
12/31/2012
12/31/2011
Assets
Cash & Equivalents$26$44$9$196
Short-Term Investments$0$0$0$0
Receivables$0$0$28$54
Inventory$0$0$33$51
Other Curr. Assets$47$75$78$115
Total Curr. Assets$73$119$148$416
Property Plant & Equip (Net)$0$0$0$1
Goodwill$0$0$0$0
Intangibles$33$36$208$227
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$0
Total NC Assets$33$36$208$228
Other Assets$0$0$0$0
Total Assets$106$155$356$644
Liabilities
Payables$229$190$76$243
Short-Term Debt$4,983$3,989$1,554$318
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$837$527$1,345$565
Total Curr. Liab.$6,049$4,706$2,975$1,126
LT Debt$0$0$0$0
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$232$225
Total NC Liab.$0$0$232$225
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$6,049$4,706$3,207$1,351
Equity
Pref Stock$0$0$0$0
Common Stock$667$667$667$667
Retained Earnings-$18,440-$17,046-$15,341-$13,185
AOCI$0$0$0$0
Other Equity$11,830$11,828$11,823$11,811
Total Equity-$5,943-$4,551-$2,851-$707
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$106$155$356$644
Net Debt$4,957$3,945$1,545$122